May 27, 2024
Last September, the Italian Parliament approved national screening for celiac disease in children aged 1-17 years. The decision followed the publication of findings from a screening […]
May 27, 2024
TOPLINE: Patients with axial spondyloarthritis (axSpA) who reported high nonsteroidal anti-inflammatory drug (NSAID) use did not have a higher risk for hypertension than those who reported […]
May 26, 2024
STOCKHOLM — People with difficult to diagnose kidney diseases linked to nephrotic syndrome show uniquely high levels of antinephrin autoantibodies, suggesting a novel biomarker and breakthrough […]
May 26, 2024
STOCKHOLM — Improvements in kidney function outcomes observed with glucagon-like peptide-1 (GLP-1) receptor agonists in patients with type 2 diabetes extend to patients who are overweight […]
May 25, 2024
In a 7 to 4 vote, an advisory panel to the US Food and Drug Administration (FDA) determined that the potential benefits of the investigational once-weekly […]
May 24, 2024
STOCKHOLM — Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has shown significant benefits in preventing major kidney disease, cardiovascular events, as well as mortality in patients […]
May 24, 2024
About 45,000 people will descend on Chicago next week, starting on May 31 to June 4, for the American Society of Clinical Oncology (ASCO) annual meeting. […]
May 24, 2024
Canada’s colorectal cancer (CRC) screening programs, which are run at the provincial or territorial level, meet the International Agency for Research on Cancer’s (IARC) criteria for […]
May 24, 2024
NEW ORLEANS — Medications in development would preserve muscle mass and augment fat loss when used in combination with glucagon-like peptide 1 (GLP-1) receptor agonists taken […]
Prev page
123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148149150151152153154155156157158159160161162163164165166167168169170171172173174175176177178179180181182183184185186187188189190191192193194195196197198199200201202203204205206207208209210211212213214215216217218219220221222223224225226227228229230231232233234235236237238239240241242243244245246247248249250251252253254255256257258259260261262263264265266267268269270271272273274275276277278279280281282283284285286287288289290291292293294295296297298299300301302303304305306307308309310311312313314315316317318319320321322323324325326327328329330331332333334335336337338339340341342343344345346347348349350351352353354355356357358359360361362363364365366367368369370371372373374375376377378379380381382383384385386387388389390391392393394395396397398399400401402403404405406407408409410411412413414415416417418419420421422423424425426427428429430431432433434435436437438439440441442443444445446447448449450451452453454455456457458459460461462463464465466467468469470471472473474475476477478479480481482483484485486487
Next page